Is Allergan Worth More or Less After J&J Buys Mentor? (MNT, JNJ, AGN)

December 1, 2008 · Filed Under General · Comments Off 

You have probably heard about the acquisition where Johnson & Johnson (NYSE: JNJ) is acquiring Mentor Corp. (NYSE: MNT).  Frankly, now that we took a look this deal is not at all that surprising and we are not that surprised that the $31.00 is nearly a 100% premium to Friday’s price of Mentor.  But what is surprising is that the merger is putting severe pressure today on Allergan Inc. (NYSE: AGN).
Read more

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed